By using flow cytometry, we could dive further into the activation status of T cells, thereby detecting increased expression of CD39, CD69, and programmed cell death protein 1 (PD-1) in the tumor, whereas CD127 expression was reduced. This evidence concerns the gene ENTPD1 and neoplasm.